Physician profile
Kumar Shah
NPI 1538351986
$4,762.97
in general payments reported to CMS, 2019-2025
24 companies · $2,847 in 2025
The $2,847 reported for 2025 was more than what 89% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2021: $94.00 · 2022: $205 · 2023: $576 · 2024: $761 · 2025: $2,847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,185.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,041.48 | 2021-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $971.43 | 2021-2025 | Nucala, Trelegy Ellipta, Shingrix |
| Regeneron Healthcare Solutions, INC. | $316.24 | 2021-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $290.85 | 2024-2025 | Uptravi, Opsumit |
| Abiomed | $278.46 | 2019 | |
| Viatris Specialty LLC | $278.43 | 2025 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $263.12 | 2021-2025 | Jardiance, Ofev, Jascayd |
| Verona Pharma, INC. | $262.68 | 2025 | Ohtuvayre |
| Genzyme Corporation | $182.96 | 2022-2025 | |
| Imperative Care, INC | $150.27 | 2025 | Symphony Catheter |
| Amgen INC. | $141.95 | 2022-2025 | Tezspire |
| Grifols USA, LLC | $138.14 | 2022-2025 | Prolastin-C Liquid |
| Inogen, INC. | $98.96 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Insmed, INC. | $67.14 | 2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $58.30 | 2023-2024 | Yupelri |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $45.29 | 2024 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $41.83 | 2022-2024 | Glassia |
| Baxter Healthcare | $28.99 | 2023 | Hillrom - Life 2000 Ventilation System |
| Pentax of America, INC. | $23.05 | 2021 | |
| Lilly USA, LLC | $22.51 | 2023 | Jardiance |
| Amarin Pharma, INC. | $15.98 | 2022 | |
| Novo Nordisk INC | $15.80 | 2023 | Wegovy |
| Philips North America LLC | $15.49 | 2024 | (Ak6) Vest Therapy |
| Covis Pharma Gmbh | $13.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kumar Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.